🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I/II study designed to evaluate the safety, tolerability, P...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2026-02-05
Trial ID
NCT07375758
Treatments Being Tested
The purpose of this study is to characterize the effects of 85 days treatme...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05-20
Trial ID
NCT02410499
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
This is a multicenter, randomized, double-blind, placebo-controlled phase I...
Status
Completed
Location
Beijing Tong-Ren hospital
Start Date
2023-08-10
Trial ID
NCT05908032
The study evaluates the safety of different doses of a new medicine called ...
Status
Recruiting
Location
N America Res Inst - San Dimas
Start Date
2024-12-02
Trial ID
NCT06717698
Treatments Being Tested
The purpose of this clinical trial was to evaluate efficacy and safety of o...
Status
Completed
Location
Ascendis Pharma Investigational Site
Start Date
2023-03-03
Trial ID
NCT05598320
Treatments Being Tested
This Phase I Clinical Study assessed the Safety, Tolerability, Pharmacokine...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2023-03-02
Trial ID
NCT05668403
This randomized, multicenter, double-blind, placebo-controlled, parallel-gr...
Status
Completed
Location
University Alabama At Birmingham
Start Date
2013-10-13
Trial ID
NCT01872689
Treatments Being Tested
This Study Aims to Evaluate the Safety, Tolerability and Efficacy of R2R01 ...
Status
Completed
Location
Thomas Hospital
Start Date
2024-03-01
Trial ID
NCT06264310
The main purpose of this study is to assess the safety and tolerability of ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-06
Trial ID
NCT01870297
Treatments Being Tested